• Home
  • Doctors
  • Test
  • AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR

AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR

This assay is used for the monitoring of AML patients with known AML-ETO [AML1(CBFA2, RUNX1)-ETO (MTG8)] fusion gene transcript formed due to translocation between chromosome 8 and 21 which is associated with Acute myeloid leukemia.

  • Test Type:
  • Pre-test Information:
    MRD Clinical information form with historical data is mandatory
  • Report Delivery:
    Sample by Mon / Thu 11 am; Report Wed / Sat
  • Components:

Sample Report